Why More Young Men Have Erectile Dysfunction in 2026 ?
The rise in erectile dysfunction among younger men doesn't point to one neat cause. It looks more like a traffic jam,...
Reliable shipping
Flexible returns
Our products are sourced directly from brands or authorized distributors.
Myelotib Tablets contain Nilotinib, a medication primarily used for the treatment of chronic myeloid leukemia (CML). It works by inhibiting certain proteins that promote cancer cell growth, helping to manage the condition effectively.
Nilotinib targets and blocks the activity of the BCR-ABL protein, which is responsible for the uncontrolled growth of cancer cells in CML. By inhibiting this protein, Myelotib helps to reduce the number of cancer cells in the body.
Myelotib is indicated for the treatment of adults and children who have newly diagnosed CML or those who have experienced resistance or intolerance to prior therapies.
Common side effects include nausea, headache, fatigue, skin rash, and muscle pain. More serious side effects may include heart problems, liver issues, and low blood cell counts. Patients should consult their healthcare provider if they experience any unusual symptoms.
Myelotib is usually taken orally, with or without food. It is important to follow the prescribed dosage and schedule as directed by a healthcare professional. Skipping doses or altering the treatment plan without consultation can affect treatment efficacy.
Myelotib is not recommended for individuals with a known hypersensitivity to Nilotinib or any of its components. Patients with a history of heart problems or certain liver conditions should discuss these with their doctor before starting treatment.
Patients should inform their healthcare provider about all medications they are currently taking, including over-the-counter drugs and supplements, as certain medications may interact with Nilotinib and affect its efficacy or increase the risk of side effects.
Regular monitoring of blood counts, liver function, and heart health is essential during treatment with Myelotib. Patients should attend all scheduled follow-up appointments to ensure the medication is working effectively and to manage any side effects.
Myelotib Tablets (Nilotinib) are a vital option for managing chronic myeloid leukemia. It is essential for patients to work closely with their healthcare providers to ensure safe and effective treatment.
We do not dispense any prescription medicine without valid and legible prescription written by your local physician. All prescriptions must be presented from a valid verifiable and licensed physician.
We are only able to ship a maximum 90-day supply of your prescription.
All trademarks and registered trademarks are the property of their respective owners. The products mentioned on this website are trademarks of their respective owners and are not owned by or affiliated with this company or any of its associated companies.